Study of High Dose Carfilzomib in Multiple Myeloma Patients Who Have Progressed On Standard Dose Carfilzomib

NCT01775553 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Relapse Multiple Myeloma
Refractory Multiple Myeloma

Interventions

DRUG: Carfilzomib

Sponsor

Ajai Chari

Collaborators

[object Object]